Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Pars Risk Charts: A 10-Year Study of Risk Assessment for Cardiovascular Diseases in Eastern Mediterranean Region Publisher Pubmed



Sarrafzadegan N1, 2 ; Hassannejad R3 ; Marateb HR4, 5 ; Talaei M1, 6 ; Sadeghi M1 ; Roohafza HR1 ; Masoudkabir F7, 8 ; Oveisgharan S9, 10 ; Mansourian M3 ; Mohebian MR4 ; Mananas MA5, 11
Authors

Source: PLoS ONE Published:2017


Abstract

[No abstract available]
Related Docs
View other Related Docs
1. Developing Non-Laboratory Cardiovascular Risk Assessment Charts and Validating Laboratory and Non-Laboratory-Based Models, Global Heart (2021)
2. First Iranian Guidelines for the Diagnosis, Management, and Treatment of Hyperlipidemia in Adults, Journal of Research in Medical Sciences (2024)
3. An Office-Based Cardiovascular Prediction Model Developed and Validated in Cohort Studies of a Middle-Income Country, Journal of Clinical Epidemiology (2022)
Experts (# of related papers)
View all Related Experts
Nizal Sarrafzadegan (18)
Masoumeh Sadeghi (9)
Other Related Docs
4. An Evolutionary Machine Learning Algorithm for Cardiovascular Disease Risk Prediction, PLoS ONE (2022)
5. Cardiovascular Disease Risk Prediction Among Iranian Patients With Diabetes Mellitus in Isfahan Province, Iran, in 2014, by Using Framingham Risk Score, Atherosclerotic Cardiovascular Disease Risk Score, and High-Sensitive C-Reactive Protein, ARYA Atherosclerosis (2018)
6. Methods of Sampling and Sample Size Determination of a Comprehensive Integrated Community-Based Interventional Trial: Isfahan Healthy Heart Program, ARYA Atherosclerosis (2018)
7. Anthropometric Indices Predicting Incident Type 2 Diabetes in an Iranian Population: The Isfahan Cohort Study, Diabetes and Metabolism (2013)
8. Prediction of Cardiovascular Disease Mortality in a Middle Eastern Country: Performance of the Globorisk and Score Functions in Four Population-Based Cohort Studies of Iran, International Journal of Health Policy and Management (2022)
9. Left Ventricular Diastolic Function in Subjects With Metabolic Syndrome: Isfahan Cohort Study, Iranian Heart Journal (2013)
10. Does the Impact of Metabolic Syndrome on Cardiovascular Events Vary by Using Different Definitions? Chronic Disease Epidemiology, BMC Public Health (2015)
11. Prognostic Validation of a Non-Laboratory and a Laboratory Based Cardiovascular Disease Risk Score in Multiple Regions of the World, Heart (2018)
12. Longitudinal Association of Dietary Habits and the Risk of Cardiovascular Disease Among Iranian Population Between 2001 and 2013: The Isfahan Cohort Study, Scientific Reports (2023)
13. Cardiovascular Disease in Iran in the Last 40 Years: Prevalence, Mortality, Morbidity, Challenges and Strategies for Cardiovascular Prevention, Archives of Iranian Medicine (2019)
14. The Isfahan Cohort Study: Rationale, Methods and Main Findings, Journal of Human Hypertension (2011)
15. Isfahan Healthy Heart Program, Sample Size and Sampling Structure: A Comprehensive Report, Journal of Isfahan Medical School (2016)
16. Long-Term Exposure to Pm2.5 and Cardiovascular Disease Incidence and Mortality in an Eastern Mediterranean Country: Findings Based on a 15-Year Cohort Study, Environmental Health: A Global Access Science Source (2021)
17. Anthropometric Indices Predicting Incident Hypertension in an Iranian Population: The Isfahan Cohort Study, Anatolian Journal of Cardiology (2019)
18. Risk and Age of Cardiovascular Event in Women With Metabolic Syndrome: Menopause Age in Focus, Metabolic Syndrome and Related Disorders (2018)
19. Cardiometabolic Risk Factors and Framingham Risk Score in Severely Obese Patients: Baseline Data From Dietbra Trial, Nutrition, Metabolism and Cardiovascular Diseases (2020)
20. The Influence of Gender and Place of Residence on Cardiovascular Diseases and Their Risk Factors. the Isfahan Cohort Study, Saudi Medical Journal (2012)